Cookie Einstellungen
Diese Webseite verwendet Cookies. Bitte wählen Sie aus, welche Cookies Sie zulassen möchten. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig    Statistik    Marketing   Details einblenden
Auswahl speichern       Alle auswählen
Impact News +++ Kinnate Biopharma Inc. to Present Preclinical Data on its FGFR Inhibitor Candidate at the ASCO... (GlobeNewswire EN) +++ KINNATE Aktie -4,22%

FENNEC Aktie

 >FENNEC Aktienkurs 
3.98 EUR    (Tradegate)
Ask: 4.08 EUR / 490 Stück
Bid: 3.88 EUR / 516 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
>FENNEC Performance
1 Woche: -4,1%
1 Monat: +7,0%
3 Monate: -48,0%
6 Monate: -28,3%
1 Jahr: -37,8%
laufendes Jahr: +6,7%
>FENNEC Aktie
Name:  FENNEC PHARMACEUT.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA31447P1009 / A12A5F
Symbol/ Ticker:  RV41 (Frankfurt) / FENC (NASDAQ)
Kürzel:  FRA:RV41, ETR:RV41, RV41:GR, NASDAQ:FENC
Index:  -
Webseite:  https://fennecpharma.com/
Marktkapitalisierung:  95.14 Mio. EUR
Umsatz:  0.15 Mio. EUR
EBITDA:  -
Gewinn je Aktie:  -0.485 EUR
Schulden:  4.4 Mio. EUR
Liquide Mittel:  21.47 Mio. EUR
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  614.43 / 5.5 / -
Gewinnm./ Eigenkapitalr.:  - / -64.37%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  FENNEC
Letzte Datenerhebung:  19.01.22
>FENNEC Eigentümer
Aktien: 26.01 Mio. St.
f.h. Aktien: 17.6 Mio. St.
Insider Eigner: 16.94%
Instit. Eigner: 44.82%
Leerverk. Aktien: 1.72%
>FENNEC Peer Group

 
13.12.21 - 16:25
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (PR Newswire)
 
NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fennec Pharmaceuticals Inc. ("Fennec" or the "Company") (NASDAQ: FENC). Such investors are advised to contact Robert S. Willoughby at newaction@po...
30.11.21 - 23:39
Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down (Zacks)
 
Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading....
30.11.21 - 20:40
Form 8-K FENNEC PHARMACEUTICALS For: Nov 30 (SEC Filing)
 
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...
30.11.21 - 12:26
Fennec Gets Official Notice of FDA Rejection of Pedmark >FENC (MarketWatch)
 
Fennec Gets Official Notice of FDA Rejection of Pedmark >FENC...
30.11.21 - 12:21
Fennec Pharma receives FDA CRL for Pedmark application in solid tumors (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.11.21 - 12:03
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors (GlobeNewswire EN)
 
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter (CRL) on November 29, 2021 from the U.S. Food and Drug Adm...
29.11.21 - 17:09
Krystal Biotech, Petros Pharmaceuticals leads healthcare gainers; Fennec Pharmaceuticals, Allied Healthcare Products among major losers (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.11.21 - 16:38
Form 8-K FENNEC PHARMACEUTICALS For: Nov 29 (SEC Filing)
 
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...
29.11.21 - 16:26
Fennec Shares Plunge as Pedmark Appears Headed for FDA Rejection >FENC (MarketWatch)
 
Fennec Shares Plunge as Pedmark Appears Headed for FDA Rejection >FENC...
29.11.21 - 14:27
Celularity, Longeveron, Fennec Pharmaceuticals among major healthcare premarket losers′ pack (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.11.21 - 13:42
Fennec Pharma Stock Plunges On Expected FDA CRL For Pedmark For Chemo-Induced Hearing Issues (Benzinga)
 
Fennec Pharmaceuticals Inc (NASDAQ: FENC) said it read more...
29.11.21 - 12:46
UPDATE 1-Fennec Pharma expects FDA to decline application for hearing loss drug (Reuters EN)
 
...(Adds share price, background) Nov 29 (Reuters) - Fennec......
29.11.21 - 12:42
Fennec Pharma down 40% as company expects to receive FDA Complete Response Letter for Pedmark (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.11.21 - 12:32
Fennec Pharmaceuticals Expects FDA to Reject Pedmark Application Again (MarketWatch)
 
Fennec Pharmaceuticals Expects FDA to Reject Pedmark Application Again...
29.11.21 - 12:22
Fennec expects U.S. FDA to decline application for hearing loss drug (Reuters EN)
 
...(Reuters) - Fennec Pharmaceuticals Inc said on Monday it expects......
29.11.21 - 12:03
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors (GlobeNewswire EN)
 
FDA Pre-Approval Inspection Identified Deficiencies with the Facility of the Drug Product Manufacturer, Which Require Resolution Prior to PEDMARK Approval FDA Pre-Approval Inspection Identified Deficiencies with the Facility of the Drug Product Manuf...
21.11.21 - 21:18
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week (Benzinga)
 
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week. read more...
10.11.21 - 12:33
Fennec Pharmaceuticals EPS beats by $0.01 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.11.21 - 12:03
Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire EN)
 
~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~...
30.10.21 - 01:21
Fennec Pharmaceuticals: Will Pedmark Make It To Market At Second Time Of Asking? (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Der errichten will, braucht Mitarbeiter, der zerstören will braucht Helfershelfer. - Freifrau Marie von Ebner-Eschenbach
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!